Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-1230
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-10-01T06:55:13.210834Z
status: published
lens: g_space
sector: health
headline: Identification and Experimental Validation of PANoptosis Key Genes for Constructing a PANoptosis Risk Diagnostic Model in Intervertebral Disc Degeneration
dek: Background Intervertebral disc degeneration (IDD) represents a significant health concern globally. This study aimed to identify the PANoptosis key genes (PKGs) associated with IDD and construct a risk diagnosis model METHODS: Single-cell sequencing, machine learning algorithms, and LASSO regression were employed to identify PKGs and develop a risk model. The expression of identified PKGs was validated in human IDD clinical tissues using qRT-PCR, Western blot, and immunohistochemistry. The therapeutic effect of…
gain_title: Researchers used machine learning and LASSO regression on single-cell data to identify seven PANoptosis key genes and build a validated IDD risk diagnosis model, with experimental knockdown of ACSBG1 reducing degeneration in a rat model.
problem_title: (none)
trace_subject: (none)
gain_reading: Researchers used machine learning and LASSO regression on single-cell data to identify seven PANoptosis key genes and build a validated IDD risk diagnosis model, with experimental knockdown of ACSBG1 reducing degeneration in a rat model.
gain_evidence: Single-cell sequencing, machine learning algorithms, and LASSO regression were employed to identify PKGs and develop a risk model. | an IDD PANoptosis risk diagnosis model was constructed and validated | ACSBG1 knockdown markedly attenuated disc degeneration, preserving disc structure and increasing proteoglycan content
problem_reading: (none)
problem_evidence: (none)
quick_read: By October 2026, researchers reported using single-cell sequencing and machine learning to pinpoint seven PANoptosis-related genes associated with intervertebral disc degeneration and to build a risk diagnosis model. They validated expression patterns in patient nucleus pulposus samples and tested ACSBG1 knockdown in rats.

The work matters because it moves from computational gene selection to tissue-level confirmation and an in vivo therapeutic demonstration, suggesting a diagnostic and targetable pathway for a common spine condition. What remains uncertain from the text is model performance metrics, patient cohort size, and durability or safety of ACSBG1 targeting beyond the reported histology.
limitation: 
tag: Evidence-backed gain
key_points: Study identified seven representative PANoptosis key genes: ACSBG1, FXYD1, APCS, CEACAM1, ERAP2, ABL1, and FZD3 for intervertebral disc degeneration. | Risk model was built from those genes and linked to immune infiltration, particularly neutrophils. | Clinical validation by qRT-PCR, Western blot, and immunohistochemistry showed four genes upregulated and three downregulated in patient nucleus pulposus tissues. | In vivo testing showed ACSBG1 knockdown preserved disc structure and increased proteoglycan content in rats.
rundown: The team combined single-cell sequencing with machine learning and LASSO regression to select seven PKGs and construct the risk model, then performed immune infiltration analysis.

Validation included qRT-PCR, Western blot, and immunohistochemistry on human IDD clinical nucleus pulposus tissues, confirming directional expression changes, and histological analysis of a rat IDD model after ACSBG1 knockdown.
sources:
- peer_reviewed | The Journal of Gene Medicine | https://doi.org/10.1002/jgm.70115 | 2026-10-01
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

412dc5686048dfee16a82e597f6ba941f9cddd892b0072daeaaafbc093f744cc

previous

0000000000000000000000000000000000000000000000000000000000000000